bpc 157 hims Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here's what happens next Hims & Hers stock rises

The closest analog (cagrilintide + semaglutide) has Phase 3 data showing meaningful additive benefit over semaglutide alone

The SURPASS-3 MRI substudy added another layer, showing tirzepatide actually reduced muscle fat infiltration across all doses, indicating improved muscle quality even as total muscle volume decreased

Gastrointestinal Issues In addition to nausea, individuals can have more nonspecific gastrointestinal distress-like diarrhea or bloating

Study Design Considerations Research protocols must specify exact dosing schedules and concentrations

"Despite the fact there's no evidence and real potential harm." Jiang did not respond to CBC's repeated requests for comment